CCO Conference Highlights of the ESMO 2019 Congress

September 27 - October 1, 2019; Barcelona, Spain
Download this summary slideset of the key data in breast cancer, gastrointestinal cancers, gynecologic cancers, and thoracic malignancies from the 2019 Oncology meeting in Barcelona!
Axel Grothey Headshot
Axel Grothey, MD
Sara Hurvitz, MD, FACP
Bradley J. Monk, MD, FACS, FACOG
Sandip P. Patel, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.53 MB
Released: October 10, 2019

Acknowledgements

Supported by educational grants from
AbbVie
Agios Pharmaceuticals
Bristol-Myers Squibb
Eisai
PharmaMar

Related Content

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2022, from Clinical Care Options (CCO)

David Scott Miller, MD, FACOG, FACS Angeles Alvarez Secord, MD, MHSc Released: June 22, 2022

Phase III MITO23: data on trabectedin vs investigator’s choice of chemotherapy in BRCA-mutant or BRCAness phenotype recurrent ovarian cancer, presented at ASCO 2022 and reported by Clinical Care Options (CCO)

Released: June 17, 2022

Update of ATEZO-BRAIN trial evaluating atezolizumab plus chemotherapy in patients with advanced nonsquamous NSCLC with untreated brain metastases, presented at ASCO 2022 and reported by Clinical Care Options (CCO)

Released: June 16, 2022

Results from LUMINA trial showing very low local recurrence rate with omission of radiotherapy after breast-conserving surgery in patients with low-risk luminal A breast cancer, presented at ASCO 2022 and reported by Clinical Care Options (CCO)

Released: June 15, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings